Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122466) titled 'Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy' on Aug. 7.
Study Type: Observational
Primary Sponsor: Northwell Health
Condition:
Metastatic Pancreatic Cancer
Intervention:
Diagnostic Test: Tumor DNA circulating in the bloodstream (circulating tumor DNA
Recruitment Status: Not recruiting
Date of First Enrollment: May 22, 2023
Target Sample Size: 24
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07122466
Published by HT Digital Content Services with permission from Health Daily Digest....